Myeloproliferative neoplasms trials in Germany

27 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Tasquinimod in Patients with Myelofibrosis Refractory to or Intolerant for JAK2 Inhibition

  Where

  Aachen

  Age

  18 years and over

  People

  20 worldwide

  Run by

  Stichting Hemato-Oncologie voor Volwassenen Nederland

  See details and how to joinNCT06605586 · EU 2024-511565-11-00
• Phase 1/2Taking people
  Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

  Where

  Düsseldorf, Halle

  Age

  18 years and over

  People

  70 worldwide

  Run by

  Telios Pharma, Inc.

  See details and how to joinNCT05280509